304 related articles for article (PubMed ID: 19299146)
1. Design, synthesis and SAR studies of tripeptide analogs with the scaffold 3-phenylpropane-1,2-diamine as aminopeptidase N/CD13 inhibitors.
Shang L; Fang H; Zhu H; Wang X; Wang Q; Mu J; Wang B; Kishioka S; Xu W
Bioorg Med Chem; 2009 Apr; 17(7):2775-84. PubMed ID: 19299146
[TBL] [Abstract][Full Text] [Related]
2. Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).
Shang L; Wang Q; Fang H; Mu J; Wang X; Yuan Y; Wang B; Xu W
Bioorg Med Chem; 2008 Dec; 16(23):9984-90. PubMed ID: 18996018
[TBL] [Abstract][Full Text] [Related]
3. Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.
Zhang X; Fang H; Zhu H; Wang X; Zhang L; Li M; Li Q; Yuan Y; Xu W
Bioorg Med Chem; 2010 Aug; 18(16):5981-7. PubMed ID: 20637634
[TBL] [Abstract][Full Text] [Related]
4. The synthesis and preliminary activity assay in vitro of peptide-like derivatives as APN inhibitors.
Li SH; Li G; Huang HM; Xiong F; Liu CM; Tu GG
Arch Pharm Res; 2008 Oct; 31(10):1231-9. PubMed ID: 18958412
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel L-isoserine tripeptide derivatives as aminopeptidase N inhibitors.
Pan H; Yang K; Zhang J; Xu Y; Jiang Y; Yuan Y; Zhang X; Xu W
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):717-26. PubMed ID: 22545941
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.
Liu Y; Shang L; Fang H; Zhu H; Mu J; Wang Q; Wang X; Yuan Y; Xu W
Bioorg Med Chem; 2009 Oct; 17(20):7398-404. PubMed ID: 19782572
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel L-lysine ureido derivatives as aminopeptidase N inhibitors.
Su L; Fang H; Yang K; Xu Y; Xu W
Bioorg Med Chem; 2011 Jan; 19(2):900-6. PubMed ID: 21194957
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.
Zhang X; Zhang J; Zhang L; Feng J; Xu Y; Yuan Y; Fang H; Xu W
Bioorg Med Chem; 2011 Oct; 19(20):6015-25. PubMed ID: 21911297
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors.
Su L; Jia Y; Zhang L; Xu Y; Fang H; Xu W
Bioorg Med Chem; 2012 Jun; 20(12):3807-15. PubMed ID: 22607877
[TBL] [Abstract][Full Text] [Related]
10. Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Structure-based design, chemistry and activity evaluation. II.
Li Q; Fang H; Wang X; Xu W
Eur J Med Chem; 2010 Apr; 45(4):1618-26. PubMed ID: 20129718
[TBL] [Abstract][Full Text] [Related]
11. Novel indoline-2,3-dione derivatives as inhibitors of aminopeptidase N (APN).
Jin K; Zhang X; Ma C; Xu Y; Yuan Y; Xu W
Bioorg Med Chem; 2013 May; 21(9):2663-70. PubMed ID: 23510562
[TBL] [Abstract][Full Text] [Related]
12. Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Design, chemistry and activity evaluation. Part I.
Li Q; Fang H; Wang X; Hu L; Xu W
Eur J Med Chem; 2009 Dec; 44(12):4819-25. PubMed ID: 19683842
[TBL] [Abstract][Full Text] [Related]
13. Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.
Jia M; Yang K; Fang H; Xu Y; Sun S; Su L; Xu W
Bioorg Med Chem; 2011 Sep; 19(17):5190-8. PubMed ID: 21802307
[TBL] [Abstract][Full Text] [Related]
14. Novel potent 2,5-pyrrolidinedione peptidomimetics as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.
Li Q; Fang H; Wang X; Hu G; Wang Q; Xu W
Bioorg Med Chem Lett; 2012 Jan; 22(2):850-3. PubMed ID: 22206607
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.
Wang Q; Chen M; Zhu H; Zhang J; Fang H; Wang B; Xu W
Bioorg Med Chem; 2008 May; 16(10):5473-81. PubMed ID: 18467109
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Bioorg Med Chem; 2008 Sep; 16(17):7932-8. PubMed ID: 18718763
[TBL] [Abstract][Full Text] [Related]
17. Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).
Li X; Wang J; Li J; Wu J; Li Y; Zhu H; Fan R; Xu W
Bioorg Med Chem; 2009 Apr; 17(8):3053-60. PubMed ID: 19329328
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 1,3,4-thiadiazole derivatives as aminopeptidase N inhibitors.
Li SH; Li G; Huang HM; Xiong F; Mai X; Kuang BH; Liu CM; Tu GG
Pharmazie; 2009 Feb; 64(2):67-70. PubMed ID: 19320275
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of a novel series of L-isoserine derivatives as aminopeptidase N inhibitors.
Yang K; Fen J; Fang H; Zhang L; Gong J; Xu W
J Enzyme Inhib Med Chem; 2012 Apr; 27(2):302-10. PubMed ID: 21770859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
